Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Phase II study with a combination of epirubicin, cisplatin, UFT, and leucovorin in advanced hepatocellular carcinoma

Published:2005-07-28 Issue:4 Volume:57 Page:436-442
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Kim Seok Jin,Seo Hee Yun,Choi Jong Gwon,Sul Hye Ryoung,Sung Hwa Jung,Park Kyong Hwa,Choi In Keun,Oh Sang Cheul,Yoon So Young,Seo Jae Hong,Choi Chul Won,Kim Byung Soo,Shin Sang Won,Kim Yeul Hong,Kim Jun Suk

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-005-0067-7.pdf

Reference36 articles.

1. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168–174

2. Johnson PJ (2002) Hepatocellular carcinoma: is current therapy really altering outcome? Gut 51:459–462

3. Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–799; discussion 799–800

4. Balsells J, Charco R, Lazaro JL, Murio E, Vargas V, Allende E, Margarit C (1996) Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 83:758–761

5. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principle active metabolites of Pinus morrisonicolaHayata synergistically inhibit cell proliferation and autophagy to elevate apoptosis in hepatocellular carcinoma cells;Environmental Toxicology;2023-08-24

2. diTFPP, a Phenoxyphenol, Sensitizes Hepatocellular Carcinoma Cells to C2-Ceramide-Induced Autophagic Stress by Increasing Oxidative Stress and ER Stress Accompanied by LAMP2 Hypoglycosylation;Cancers;2022-05-20

3. Medical Therapy of HCC;Hepatocellular Carcinoma;2016

4. Progesterone augments epirubicin-induced apoptosis in HA22T/VGH cells by increasing oxidative stress and upregulating Fas/FasL;Journal of Surgical Research;2014-05

5. Progesterone Increases Apoptosis and Inversely Decreases Autophagy in Human Hepatoma HA22T/VGH Cells Treated with Epirubicin;The Scientific World Journal;2014